KYMR logo

Kymera Therapeutics, Inc. (KYMR) Accounts Payable

Annual Accounts Payable:

$5.99M-$1.09M(-15.35%)
December 31, 2024

Summary

  • As of today, KYMR annual accounts payable is $5.99 million, with the most recent change of -$1.09 million (-15.35%) on December 31, 2024.
  • During the last 3 years, KYMR annual accounts payable has risen by +$1.98 million (+49.54%).
  • KYMR annual accounts payable is now -15.35% below its all-time high of $7.08 million, reached on December 31, 2023.

Performance

KYMR Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Quarterly Accounts Payable:

$5.51M-$275.00K(-4.76%)
September 30, 2025

Summary

  • As of today, KYMR quarterly accounts payable is $5.51 million, with the most recent change of -$275.00 thousand (-4.76%) on September 30, 2025.
  • Over the past year, KYMR quarterly accounts payable has dropped by -$988.00 thousand (-15.21%).
  • KYMR quarterly accounts payable is now -46.35% below its all-time high of $10.26 million, reached on March 31, 2025.

Performance

KYMR Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKYMRbalance sheet metrics

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

KYMR Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-15.3%-15.2%
3Y3 Years+49.5%-13.0%
5Y5 Years+82.8%+38.4%

KYMR Accounts Payable Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-15.3%+49.5%-46.4%+47.0%
5Y5-Year-15.3%+82.8%-46.4%+131.9%
All-TimeAll-Time-15.3%+191.3%-46.4%+131.9%

KYMR Accounts Payable History

DateAnnualQuarterly
Sep 2025
-
$5.51M(-4.8%)
Jun 2025
-
$5.78M(-43.7%)
Mar 2025
-
$10.26M(+71.4%)
Dec 2024
$5.99M(-15.3%)
$5.99M(-7.8%)
Sep 2024
-
$6.49M(-0.2%)
Jun 2024
-
$6.51M(-4.4%)
Mar 2024
-
$6.81M(-3.7%)
Dec 2023
$7.08M(+63.2%)
$7.08M(+42.1%)
Sep 2023
-
$4.98M(+32.9%)
Jun 2023
-
$3.75M(-42.2%)
Mar 2023
-
$6.48M(+49.6%)
Dec 2022
$4.33M
$4.33M(-31.5%)
DateAnnualQuarterly
Sep 2022
-
$6.33M(+166.5%)
Jun 2022
-
$2.37M(-7.5%)
Mar 2022
-
$2.57M(-35.9%)
Dec 2021
$4.00M(-8.3%)
$4.00M(-20.4%)
Sep 2021
-
$5.03M(-38.4%)
Jun 2021
-
$8.18M(-2.0%)
Mar 2021
-
$8.35M(+91.1%)
Dec 2020
$4.37M(+33.3%)
$4.37M(+9.8%)
Sep 2020
-
$3.98M(-0.1%)
Jun 2020
-
$3.98M(+21.6%)
Dec 2019
$3.28M(+59.3%)
$3.28M
Dec 2018
$2.06M
-

FAQ

  • What is Kymera Therapeutics, Inc. annual accounts payable?
  • What is the all-time high annual accounts payable for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. annual accounts payable year-on-year change?
  • What is Kymera Therapeutics, Inc. quarterly accounts payable?
  • What is the all-time high quarterly accounts payable for Kymera Therapeutics, Inc.?
  • What is Kymera Therapeutics, Inc. quarterly accounts payable year-on-year change?

What is Kymera Therapeutics, Inc. annual accounts payable?

The current annual accounts payable of KYMR is $5.99M

What is the all-time high annual accounts payable for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high annual accounts payable is $7.08M

What is Kymera Therapeutics, Inc. annual accounts payable year-on-year change?

Over the past year, KYMR annual accounts payable has changed by -$1.09M (-15.35%)

What is Kymera Therapeutics, Inc. quarterly accounts payable?

The current quarterly accounts payable of KYMR is $5.51M

What is the all-time high quarterly accounts payable for Kymera Therapeutics, Inc.?

Kymera Therapeutics, Inc. all-time high quarterly accounts payable is $10.26M

What is Kymera Therapeutics, Inc. quarterly accounts payable year-on-year change?

Over the past year, KYMR quarterly accounts payable has changed by -$988.00K (-15.21%)
On this page